Check made out to: North Star Cancer Research Foundation

Address to send check:

8052 Monticello Ave.
Suite 205A
Skokie, IL 60076

<span fr-original-style="color: rgb(69, 14, 93); font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;" id="isPasted" style="color: rgb(69, 14, 93); font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; box-sizing: inherit;">100% of your donation fuels the next breakthrough testing TEQ103 + NK cells on MBC tumors from real patients. 1000 people each raising or personally donating $100 will get us to our goal! TEQ103 (also known as ErSO-TFPy) has demonstrated an unprecedented ability to kill breast cancer cells in metastatic models where cancer has spread around the body. It is currently undergoing the high-level safety testing required before it can be tested in humans. This next level of research will be conducted in the labs of Dr. David Shapiro and Dr. Paul Hergenrother, who originally developed TEQ103. They will be presenting their research (including new data on Triple Negative Breast Cancer) as part of a Q&amp;A on October 7 &amp; October 15 to the community via zoom. If you would like to participate, you can RSVP at checkout. Metastatic Breast Cancer is currently considered incurable because once cancer cells have begun to spread around the body they continue to adapt for survival and eventually, treatments, which were initially effective, stop working.&nbsp; In anticipation that some cancer cells will resist being killed by TEQ103, North Star Cancer Research Foundation is supporting the next level of TEQ103 research development as a treatment that can be used in combination with immunotherapies. TEQ103 has demonstrated a preliminary ability to stimulate the immune system to kill breast cancer cells, which may then make it more difficult for breast cancer cells to adapt and escape death. We want to help transform Breast Cancer Awareness Month into Metastatic Breast Cancer (MBC) Cures Month because MBC is the only type of breast cancer that is 99% incurable and lethal. &nbsp;Will you join us by spreading the word of our community campaign: 1000 people each personally donating or fundraising $100 in their communities to reach our $100K goal by the end of October. As federal cancer research funding is being slashed, we have faith in our community to come together and keep this very promising drug development research moving forward NOW! Let&#39;s end Metastatic Breast Cancer TOGETHER! To learn more visit our website: NorthStarCancerResearch.org **At the donation checkout page, you can change the percentage of donation given to Zeffy to zero or to an amount of your choosing. There are also options to send us a check for donations over $1000.

Hello <span contenteditable="false" data-custom-variable="{{firstname}}" fr-original-class="fr-deletable styled-tag-chip" fr-original-style="" style="background-color: rgb(248, 248, 255); border: 1px solid rgb(191, 191, 255); border-radius: 4px; color: rgb(42, 42, 196); padding: 1px 8px; font-size: 11px; display: inline-block; margin: 0px; overflow-wrap: anywhere; user-select: none; box-sizing: inherit;">First name, Thank you from the bottom of our hearts for supporting this research for metastatic breast cancer.&nbsp; 100% of your donation will go towards Dr. Shapiro&#39;s and Dr. Hergenrother&#39;s research on the promising treatment combination of TEQ103 and Natural Killer cells.&nbsp;&nbsp; If you would like to contribute further to our cause, please contact us! Carolyn Leigh &amp; Safa SabanovicNorth Star Cancer Research Foundation310-365-6855nscrfoundation@yahoo.com

100% of your donation fuels the next breakthrough testing TEQ103 + NK cells on MBC tumors from real patients. 1000 people each raising or personally donating $100 will get us to our goal! TEQ103 (also known as ErSO-TFPy) has demonstrated an unprecedented ability to kill breast cancer cells in metastatic models where cancer has spread around the body. It is currently undergoing the high-level safety testing required before it can be tested in humans. This next level of research will be conducted in the labs of Dr. David Shapiro and Dr. Paul Hergenrother, who originally developed TEQ103. They will be presenting their research (including new data on Triple Negative Breast Cancer) as part of a Q&amp;A on October 7 &amp; October 15 to the community via zoom. If you would like to participate, you can RSVP at checkout. Metastatic Breast Cancer is currently considered incurable because once cancer cells have begun to spread around the body they continue to adapt for survival and eventually, treatments, which were initially effective, stop working.  In anticipation that some cancer cells will resist being killed by TEQ103, North Star Cancer Research Foundation is supporting the next level of TEQ103 research development as a treatment that can be used in combination with immunotherapies. TEQ103 has demonstrated a preliminary ability to stimulate the immune system to kill breast cancer cells, which may then make it more difficult for breast cancer cells to adapt and escape death. We want to help transform Breast Cancer Awareness Month into Metastatic Breast Cancer (MBC) Cures Month because MBC is the only type of breast cancer that is 99% incurable and lethal.  Will you join us by spreading the word of our community campaign: 1000 people each personally donating or fundraising $100 in their communities to reach our $100K goal by the end of October. As federal cancer research funding is being slashed, we have faith in our community to come together and keep this very promising drug development research moving forward NOW! Let's end Metastatic Breast Cancer TOGETHER! To learn more visit our website: NorthStarCancerResearch.org **At the donation checkout page, you can change the percentage of donation given to Zeffy to zero or to an amount of your choosing. There are also options to send us a check for donations over $1000.

A Potential Cure For Metastatic Breast Cancer

IsFundraiserFormEditDisabled

IsPaymentByPadAllowed

North Star Cancer Research Foundation

### Context Profile for North Star Cancer Research Foundation

1. **Organization Mission & Cause**:
   - **Mission**: The North Star Cancer Research Foundation is dedicated to advancing research for metastatic breast cancer (MBC), which is currently deemed incurable. Their goal is to fund innovative research, particularly focusing on a promising drug known as TEQ103, which shows potential in treating MBC by killing cancer cells and stimulating the immune system.
   - **Cause**: The foundation aims to transform Breast Cancer Awareness Month into a campaign for MBC cures, raising awareness and funds to support research that could lead to breakthroughs in treatment.

2. **Type of Activities**:
   - **Fundraising Campaigns**: The most recent campaign titled "A Potential Cure For Metastatic Breast Cancer" aims to raise $100,000 by encouraging 1,000 individuals to donate or fundraise $100 each.
   - **Community Engagement**: The foundation organizes Q&A sessions with researchers to discuss ongoing research and findings related to MBC, fostering community involvement and education.
   - **Awareness Initiatives**: They focus on raising awareness about MBC, particularly during Breast Cancer Awareness Month, to highlight its severity and the need for research funding.

3. **Tone of Voice**:
   - The tone is **inspiring** and **urgent**, reflecting a strong call to action for community support. The language is accessible yet informative, aiming to engage readers emotionally and motivate them to contribute to the cause. Phrases like "Let’s end Metastatic Breast Cancer TOGETHER!" exemplify this tone.

4. **Emoji Usage**:
   - The website and campaign materials do not prominently feature emojis in their communications. The tone remains professional and serious, focusing on the gravity of the cause rather than casual or playful elements.

5. **Key Facts**:
   - **Founding Info**: Specific founding details are not provided on the website.
   - **Scale**: The organization has conducted at least three fundraising forms, indicating active engagement in fundraising efforts.
   - **Impact Metrics**: The current campaign aims to raise $100,000, highlighting the foundation's commitment to impactful research funding.
   - **Volunteer Info**: No specific volunteer information is available on the website, but community involvement is encouraged through fundraising and participation in events.

6. **Writing Guidelines**:
   - **Style**: Use clear, direct language that conveys urgency and hope. Avoid overly technical jargon unless necessary, as the audience may not be familiar with scientific terms.
   - **Call to Action**: Include strong calls to action, encouraging donations and community participation. Phrases that inspire collective effort and urgency should be prioritized.
   - **Emotional Engagement**: Use storytelling elements to connect with the audience on an emotional level, particularly regarding the impact of MBC on individuals and families.
   - **Consistency**: Maintain a consistent tone that reflects the seriousness of the cause while also inspiring hope and action.

This context profile serves as a comprehensive guide for generating personalized content that aligns with the North Star Cancer Research Foundation's mission, activities, and communication style.

Do you want to receive email updates about this research?

Would you like to register for the Q&A with the researchers on Tues, Oct 7 at 12pm CT?

Would you like to register for the Q&A with the researchers on Tues, Oct 15 at 7pm CT?